Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial

Sanofi Taps Adviser for OTC Spinoff as Buyout Firms Circle

Sanofi Probed for Market Manipulation by French Authorities

Sanofi Warning Outweighs Spinoff, Prompting €19.5 Billion Plunge

Sanofi Plans to Split Off Consumer Health Unit to Narrow Focus

Sanofi to Explore Acquisition of Cancer Drugmaker Mirati

Sanofi Was Mystery Bidder That Lost Reata to Biogen 

AstraZeneca, Sanofi RSV Drug for Infants Wins CDC Backing

Sanofi Lifts Guidance on Dupixent, Covid Vaccine Sales

LVMH to Sponsor Paris Olympics in a First for Luxury Group

Astra, Sanofi RSV Drug Approved in US for Use in Infants

Sanofi Cuts Zantac Exposure With Arbitration Win Over Boehringer